Randomized Controlled Trial of Azithromycin for Perinatal Infection Prevention

472 pregnant women undergoing labor induction were randomized to receive 2g oral Azithromycin (n=236) or no treatment (n=236) in a single-center trial. The dataset contains primary and secondary outcomes measuring perinatal infection rates, maternal and neonatal complications, delivery mode, and safety parameters. It was authored by huimin Cao and last updated on 2026-05-24.

Use Cases

• Evaluate the effectiveness of oral Azithromycin for preventing perinatal infections based on the primary outcome measure.
• Analyze maternal and neonatal complication rates based on secondary outcome data.
• Study the relationship between antibiotic prophylaxis and delivery mode based on secondary outcome variables.
• Assess safety parameters associated with Azithromycin administration during labor induction.

Strengths

• Data originates from a randomized controlled trial with 472 participants, a standard design for causal inference.
• The dataset includes both primary (overall perinatal infection) and secondary (complications, delivery mode, safety) outcomes.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The single-center design may limit generalizability of findings.

Provenance

Source

figshare

Collection Method

Single-center randomized controlled trial.

Freshness

Last updated 2026-05-24 06:45:20; freshness should be verified.